GUARANTYGuaranty • June 16th, 2022 • Panbela Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS GUARANTY (“Guaranty”) is made effective as of June 15, 2022, by Panbela Therapeutics, Inc. (f/k/a Canary Merger Holdings, Inc.), a Delaware corporation (“Guarantor”), in favor of Sucampo GmbH (f/k/a Sucampo AG), a Swiss corporation (“Creditor”). Initially capitalized terms used herein and not otherwise defined herein have the meanings given them in the Amendment Agreement (as defined below).
CONFIDENTIAL SEPARATION AND RELEASE AGREEMENTConfidential Separation and Release Agreement • June 16th, 2022 • Panbela Therapeutics, Inc. • Pharmaceutical preparations
This Confidential Separation and Release Agreement (“Agreement”) is made by and between Jeffrey Jacob (“Employee”) and Cancer Prevention Pharmaceuticals, Inc. (“Company” or “Employer”). Employee and Employer shall be referred to herein collectively as the “Parties” or individually to as a “Party.”
